TaichmanDBBackusJBaethgeC, et al. Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. JAMA2016; 315: 467–468.
2.
DevereauxPJGuyattGGersteinH, et al. Toward fairness in data sharing. N Engl J Med2016; 375: 405–407.
3.
GibsonCM.Moving from hope to hard work in data sharing. JAMA Cardiol2018; 3: 795–796.
4.
PetersonEDRockholdFW.Finding means to fulfill the societal and academic imperative for open data access and sharing. JAMA Cardiol2018; 3: 793–794.
5.
LongoDLDrazenJM.Data sharing. N Engl J Med2016; 374: 276–277.
6.
LongoDLDrazenJM.More on data sharing. N Engl J Med2016; 374: 1896–1897.
7.
HortonR.Offline: data sharing-why editors may have got it wrong. Lancet2016; 388: 1143.
8.
TaichmanDBSahniPPinborgA, et al. Data sharing statements for clinical trials—a requirement of the International Committee of Medical Journal Editors. N Engl J Med2017; 376: 2277–2279.
9.
RockholdFWagnerE.Open science: the open clinical trials data journey. Clin Trials2019, this issue.
10.
ShabaniMObasaM.Transparency and objectivity in governance of clinical trials data sharing: current practices and approaches. Clin Trials2019, this issue.
11.
BastianHGlasziouPChalmersI.Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?PLoS Med2010; 7: e1000326.
12.
VaduganathanMNagarurAQamarA, et al. Availability and use of shared data from cardiometabolic clinical trials. Circulation2018; 137: 938–947.
13.
NavarAMPencinaMJRymerJA, et al. Use of open access platforms for clinical trial data. JAMA2016; 315: 1283–1284.
14.
DevereauxPJYusufS.When it comes to trials, do we get what we pay for?N Engl J Med2013; 369: 1962–1963.
15.
KjaergardLLVillumsenJGluudC.Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med2001; 135: 982–989.
16.
GordonDTaddei-PetersWMascetteA, et al. Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med2013; 369: 1926–1934.
17.
POISE Study Group, DevereauxPJYangH, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet2008; 371: 1839–1847.
18.
YusufSSleightPPogueJ, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med2000; 342: 145–153.
19.
GroupACPatelAMacMahonS, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med2008; 358: 2560–2572.
20.
ORIGIN Trial Investigators, BoschJGersteinHC, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med2012; 367: 309–318.
21.
ACTIVE Investigators, ConnollySJPogueJHartRG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med2009; 360: 2066–2078.
22.
CoadySAMensahGAWagnerEL, et al. Use of the National Heart, Lung, and Blood Institute data repository. N Engl J Med2017; 376: 1849–1858.
23.
SunXBrielMBusseJW, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ2012; 344: e1553.
